MedPath
HSA Approval

THEOPHYLLINE TABLETS 100 mg

SIN03139P

THEOPHYLLINE TABLETS 100 mg

THEOPHYLLINE TABLETS 100 mg

June 2, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R03DA04

theophylline

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

THEOPHYLLINE ANHYDROUS

100 mg

Theophylline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

THEOPHYLLINE TABLETS 100 mg - HSA Approval | MedPath